Skip to main content
Clinical Trials/DRKS00022175
DRKS00022175
Completed
Not Applicable

Health care analysis on myocardial revascularization in patients with chronic coronary heart disease (CHD) - REVASK

InGef – Institut für angewandte Gesundheitsforschung Berlin GmbH (InGef)0 sites386 target enrollmentAugust 27, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic CHD in the form of a 2- or 3-vessel or main-vessel disease
Sponsor
InGef – Institut für angewandte Gesundheitsforschung Berlin GmbH (InGef)
Enrollment
386
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 27, 2020
End Date
January 31, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
InGef – Institut für angewandte Gesundheitsforschung Berlin GmbH (InGef)

Eligibility Criteria

Inclusion Criteria

  • (a) with chronic coronary heart disease and
  • (b) 2\- or 3\-vessel or main\-vessel disease
  • (c) who are being treated at one of the recruitment sites
  • (d) with a promptly planned intervention for myocardial revascularization

Exclusion Criteria

  • missing informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials